Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy-Reference-Cited by-同舟云学术

Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy

Published:2015-07 Issue:1 Volume:17 Page:89-100
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Wu Haodi,Lee Jaecheol,Vincent Ludovic G.,Wang Qingtong,Gu Mingxia,Lan Feng,Churko Jared M.,Sallam Karim I.,Matsa Elena,Sharma Arun,Gold Joseph D.,Engler Adam J.,Xiang Yang K.,Bers Donald M.,Wu Joseph C.

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference44 articles.

1. Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction;Ahmet;J. Pharmacol. Exp. Ther.,2008

2. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy;Asrih;Cardiovasc. Pathol.,2013

3. Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases;Baillie;FEBS J.,2009

4. Evidence for cardiomyocyte renewal in humans;Bergmann;Science,2009

5. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating;Bienengraeber;Nat. Genet.,2004

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on cardiac troponin complex: From gene expression to cardiomyopathy;Genes & Diseases;2024-11

2. Clinical trials in-a-dish for cardiovascular medicine;European Heart Journal;2024-09-13

3. Substrate mechanics unveil early structural and functional pathology in iPSC micro-tissue models of hypertrophic cardiomyopathy;iScience;2024-06

4. Integrated machine learning and multimodal data fusion for patho-phenotypic feature recognition in iPSC models of dilated cardiomyopathy;Biological Chemistry;2024-04-24

5. Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: “What Are the Tools Needed for the Job?” and “Do We Have Them?”;Cardiovascular Toxicology;2024-03-31